| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PCSA | Common Stock | Purchase | $5,925 | +2,500 | +11% | $2.37 | 25,978 | 31 Jan 2024 | Direct | F1 |
| transaction | PCSA | Common Stock | Purchase | $3,600 | +1,500 | +5.8% | $2.40 | 27,478 | 01 Feb 2024 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. |